Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Jacksonian seizure as the relapse symptom of multiple sclerosis.
Anodal tDCS increases corticospinal output and projection strength in multiple sclerosis.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability.
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Expectations of multiple sclerosis patients and their families: a qualitative study in iran.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Perceptions of caregiver distress, health behaviors, and provider health-promoting communication and their relationship to stress management in MS caregivers.
The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases.
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »